about
Croatian survey on critical results reportingLipemia: causes, interference mechanisms, detection and management.Preanalytical external quality assessment of the Croatian Society of Medical Biochemistry and Laboratory Medicine and CROQALM: finding undetected weak spots.ABCC8 polymorphisms are associated with triglyceride concentration in type 2 diabetics on sulfonylurea therapy.I index is not an accurate indicator of icteria in conjugated hyperbilirubinemia.Patient safety is not compromised by excluding microscopic examination of negative urine dipstick.K2-EDTA and K3-EDTA Greiner Tubes for HbA1c Measurement.The quality and scope of information provided by medical laboratories to patients before laboratory testing: Survey of the Working Group for Patient Preparation of the Croatian Society of Medical Biochemistry and Laboratory Medicine.Serotonin transporter polymorphism (5-HTTLPR) in Croatian population.Are serum lipids measured on stroke admission prognostic?Association of APOA5 -1131T>C polymorphism and serum lipid levels in patients with type 2 diabetes.Visual assessment of hemolysis affects patient safety.Key Performance Indicators to Measure Improvement After Implementation of Total Laboratory Automation Abbott Accelerator a3600.Precision, accuracy, cross reactivity and comparability of serum indices measurement on Abbott Architect c8000, Beckman Coulter AU5800 and Roche Cobas 6000 c501 clinical chemistry analyzers.Heterogeneity of manufacturers' declarations for lipemia interference--an urgent call for standardization.The evidence based practice for optimal sample quality for ammonia measurement.Methodological Issues in Genetic Association Studies of Inherited Thrombophilia: Original Report of Recent PracticeLower concentration of vitamin D is associated with lower DAS28 and VAS-pain scores in patients with inflammatory rheumatic diseases treated with infliximab: a pilot study
P50
Q35750363-5B5B8F51-68E7-4337-929A-288AE45624FDQ37607322-61BEF29E-560B-428E-BFB1-7B771FA1291DQ37739752-9C3C65E6-A360-4A8D-8230-06580E835AF7Q38325834-5343B1C5-CD54-4344-89A1-C5DBBE2E4BC6Q38623227-8373C87D-EFB2-4C05-9988-2A74C1134FE0Q38971544-5C30EA2D-FF0D-4E17-9C2B-AF9C527CE40CQ40143619-979CC111-B56A-4623-AF4F-0CC40B797E6AQ41063657-9524777B-DB4D-407C-B871-695CD3432F46Q43599607-8BCCEEF9-7801-4D95-827D-843C366F2BD1Q46510283-1CDD0298-8F69-4BC2-8D79-21C50142C6D3Q46624746-CF2C0D3D-5B6B-4A11-8915-2E99B339088FQ47669355-968B6AAD-85F8-4024-908C-6B4D99B946A8Q48346476-8640A025-CE4A-447C-BD71-A213CAD7A564Q50121402-94512F70-136F-4E1E-B844-380251C13780Q50779061-8D251A91-3FF4-4A3A-9089-099851CAAE8AQ53146327-1968BEAE-8A26-4409-95D9-6A3347DBB9F6Q63225014-D83AD68C-0F47-4FC1-8790-8363B6D09BCBQ95936604-5C38F0E3-977A-4691-8BE9-43A7BAD83758
P50
description
researcher ORCID ID = 0000-0001-6831-6309
@en
wetenschapper
@nl
name
Nora Nikolac Gabaj
@ast
Nora Nikolac Gabaj
@en
Nora Nikolac Gabaj
@es
Nora Nikolac Gabaj
@nl
type
label
Nora Nikolac Gabaj
@ast
Nora Nikolac Gabaj
@en
Nora Nikolac Gabaj
@es
Nora Nikolac Gabaj
@nl
prefLabel
Nora Nikolac Gabaj
@ast
Nora Nikolac Gabaj
@en
Nora Nikolac Gabaj
@es
Nora Nikolac Gabaj
@nl
P31
P496
0000-0001-6831-6309